Intellicheck Mobilisa (NASDAQ:IDN - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01), Zacks reports. Intellicheck Mobilisa had a negative net margin of 4.44% and a negative return on equity of 3.09%. The business had revenue of $5.12 million during the quarter, compared to analysts' expectations of $5.05 million.
Intellicheck Mobilisa Stock Performance
NASDAQ:IDN traded up $0.18 on Friday, hitting $5.02. The stock had a trading volume of 271,450 shares, compared to its average volume of 194,269. The company's fifty day moving average price is $5.19. Intellicheck Mobilisa has a 52 week low of $1.92 and a 52 week high of $6.49.
Analyst Ratings Changes
Separately, Wall Street Zen upgraded Intellicheck Mobilisa from a "hold" rating to a "buy" rating in a research note on Saturday.
Read Our Latest Stock Analysis on IDN
Intellicheck Mobilisa Company Profile
(
Get Free Report)
Intellicheck, Inc, a technology company, develops, integrates, and markets threat identification and identity authentication solutions for bank and retail fraud prevention, law enforcement threat identification, and mobile and handheld access control and security systems primarily in the United States.
Further Reading
Before you consider Intellicheck Mobilisa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intellicheck Mobilisa wasn't on the list.
While Intellicheck Mobilisa currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.